Total submissions: 14
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000081849 | SCV000113784 | benign | not specified | 2015-02-11 | criteria provided, single submitter | clinical testing | |
Genetic Services Laboratory, |
RCV000081849 | SCV000192789 | benign | not specified | 2013-02-08 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV000081849 | SCV000312991 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Illumina Laboratory Services, |
RCV000306969 | SCV000474476 | likely benign | Hypogonadotropic hypogonadism 5 with or without anosmia | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases allowed determination this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. |
Invitae | RCV000347837 | SCV000562422 | benign | CHARGE syndrome | 2024-01-29 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics | RCV000081849 | SCV000612720 | benign | not specified | 2017-05-03 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002311671 | SCV000846965 | likely benign | Inborn genetic diseases | 2015-09-09 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Laboratory for Molecular Medicine, |
RCV000081849 | SCV000967058 | benign | not specified | 2017-08-23 | criteria provided, single submitter | clinical testing | p.Gly2094Gly in exon 31 of CHD7: This variant is not expected to have clinical s ignificance because it does not alter an amino acid residue, is not located with in the splice consensus sequence, and has been identified in 0.65% (432/66718) o f European chromosomes by the Exome Aggregation Consortium (ExAC, http://exac.br oadinstitute.org; dbSNP rs41312172). |
Gene |
RCV001536601 | SCV001753381 | benign | not provided | 2015-03-03 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001536601 | SCV002545621 | benign | not provided | 2024-06-01 | criteria provided, single submitter | clinical testing | CHD7: BP4, BP7, BS1, BS2 |
Fulgent Genetics, |
RCV002483146 | SCV002798825 | likely benign | CHARGE syndrome; Hypogonadotropic hypogonadism 5 with or without anosmia | 2021-07-26 | criteria provided, single submitter | clinical testing | |
Clinical Genetics, |
RCV000081849 | SCV001918348 | benign | not specified | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000081849 | SCV001956887 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001536601 | SCV001964543 | likely benign | not provided | no assertion criteria provided | clinical testing |